Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
- PMID: 36459066
- PMCID: PMC9723804
- DOI: 10.1083/jcb.202207097
Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
Abstract
Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.
© 2022 Schloesser et al.
Conflict of interest statement
Disclosures: D. Schloesser, J. Sauer, E. Griesser, U. Maier-Habelsberger, K. Fundel-Clemens, I. Schlotthauer, C. Watson, F. Igney, M-J. Thomas, and K.C. El Kasmi are employees of Boehringer Ingelheim Pharma at which part of the current work was performed and conceptualized. T. Chavakis reported grants from Deutsche Forschungsgemeinschaft and grants from European Research Council during the conduct of the study. P. Murray is a member of the scientific advisory boards of Palleon Pharmaceuticals and ImCheck Pharma. These relationships have no bearing or relevance to the current work. As noted in the manuscript, the present work is the result of a close collaboration between his group and the researchers at Boehringer Ingelheim, which is funded in part by a cooperation contract (as stated). No other disclosures were reported.
Figures














References
-
- Barkal, A.A., Brewer R.E., Markovic M., Kowarsky M., Barkal S.A., Zaro B.W., Krishnan V., Hatakeyama J., Dorigo O., Barkal L.J., and Weissman I.L.. 2019. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 572:392–396. 10.1038/s41586-019-1456-0 - DOI - PMC - PubMed
-
- Barreira da Silva, R., Leitao R.M., Pechuan-Jorge X., Werneke S., Oeh J., Javinal V., Wang Y., Phung W., Everett C., Nonomiya J., et al. . 2022. Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity. Nat. immunol. 23:568–580. 10.1038/s41590-022-01153-x - DOI - PubMed
-
- Bosurgi, L., Cao Y.G., Cabeza-Cabrerizo M., Tucci A., Hughes L.D., Kong Y., Weinstein J.S., Licona-Limon P., Schmid E.T., Pelorosso F., et al. . 2017. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science. 356:1072–1076. 10.1126/science.aai8132 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous